1. Home
  2. MDXG vs BOW Comparison

MDXG vs BOW Comparison

Compare MDXG & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • BOW
  • Stock Information
  • Founded
  • MDXG 2006
  • BOW 2020
  • Country
  • MDXG United States
  • BOW United States
  • Employees
  • MDXG N/A
  • BOW N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • BOW Property-Casualty Insurers
  • Sector
  • MDXG Health Care
  • BOW Finance
  • Exchange
  • MDXG Nasdaq
  • BOW Nasdaq
  • Market Cap
  • MDXG 1.1B
  • BOW 1.2B
  • IPO Year
  • MDXG N/A
  • BOW 2024
  • Fundamental
  • Price
  • MDXG $9.12
  • BOW $33.00
  • Analyst Decision
  • MDXG Strong Buy
  • BOW Hold
  • Analyst Count
  • MDXG 5
  • BOW 5
  • Target Price
  • MDXG $12.00
  • BOW $33.60
  • AVG Volume (30 Days)
  • MDXG 650.9K
  • BOW 163.3K
  • Earning Date
  • MDXG 02-26-2025
  • BOW 02-15-2025
  • Dividend Yield
  • MDXG N/A
  • BOW N/A
  • EPS Growth
  • MDXG N/A
  • BOW 130.44
  • EPS
  • MDXG 0.52
  • BOW 1.08
  • Revenue
  • MDXG $342,804,000.00
  • BOW $389,135,000.00
  • Revenue This Year
  • MDXG $9.56
  • BOW N/A
  • Revenue Next Year
  • MDXG $9.19
  • BOW $26.70
  • P/E Ratio
  • MDXG $17.59
  • BOW $30.54
  • Revenue Growth
  • MDXG 10.93
  • BOW 107.43
  • 52 Week Low
  • MDXG $5.47
  • BOW $22.14
  • 52 Week High
  • MDXG $10.14
  • BOW $37.81
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 53.35
  • BOW N/A
  • Support Level
  • MDXG $8.50
  • BOW N/A
  • Resistance Level
  • MDXG $9.71
  • BOW N/A
  • Average True Range (ATR)
  • MDXG 0.30
  • BOW 0.00
  • MACD
  • MDXG -0.04
  • BOW 0.00
  • Stochastic Oscillator
  • MDXG 51.24
  • BOW 0.00

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About BOW Bowhead Specialty Holdings Inc. Common Stock

Bowhead Specialty Holdings Inc is engaged in providing specialty P&C products. It is a specialty insurance group that generates revenues by underwriting and offering a variety of specialty insurance products to domestic markets through three distinct underwriting divisions: Casualty, Professional Liability and Healthcare. Casualty specialize in GL coverage for risks in the construction, distribution, heavy manufacturing, real estate and hospitality segments and also consider underwriting risks in a broader range of industries. Key revenue is generated from Casualty segment.

Share on Social Networks: